Malala Yousafzai, Rihanna, and Gonzalo Ladreda - what do they all have in common? They have all made it into Forbes 30 Under 30! Our CEO, Gonzalo, has been recognised as one of Europe’s top 30 changemakers in Science & Healthcare. forbes.com/30-under-30/20… #ForbesUnder30

The winner of the ‘Development of an Innovative Device or Technology’ award sponsored by CPI is… 🌟 Point-of-Care Blood Test for the Pre-Hospital Identification of Stroke Patients Suitable for Emergency Thrombectomy Treatment by Newcastle University & @pockitdx 👏 #BIHA2022

Huge congratulations to @pockitdx & @NIHR_NCL_MIC - WINNERS 🎉 @BIHA_2022! Fantastic night celebrating #innovation, thanks Invest Newcastle & Emma Barron Northumbria Uni for the kind invitation. Brilliant day @AHSN_NENC, 🌈 Sarah Black 🌈 Nicola Hutchinson 💛

@BIHA_2022 CPI Newcastle University @pockitdx Fantastic recognition for the work of Newcastle Stroke Research and @pockitdx and the rest of the team. Hopefully coming to an ambulance near you in a few years time

Congratulations to BIVDA member @pockitdx for winning “Development of an Innovative Device or Technology” for their LVOne blood test at the Bright Ideas in Health Awards 2022 🏆 It is always a delight to see BIVDA members being recognised for their amazing innovations!

Honoured to collect the "Development of an Innovative Device or Technology" award for @pockitdx & the project team. Great to be a finalist with North East Innovation Lab for the "Innovation Champion Team Award". Amazing to meet the inspirational @nicolashamilton!😍 What a night! #BIHA2022🎊

Thank you to Stroke Association for a brilliant #AmazingBrains event yesterday highlighting mental health after stroke and celebrating innovative #SBRIHealthcare & Stroke Association funded projects @pockitdx NeuroVirt Evolv Imperial College London Cognitant Odstock & Sonalis

May is Stroke Month. Pockit Diagnostics have created a test to identify Large Vessel Occlusion (LVO) strokes. Their patented blood-based diagnostic “LVOne” test identifies LVO strokes within minutes, with 95% accuracy. Find out more ⬇️ @pockitdx innovationlibrarynenc.org.uk/result/test-id…

May is Stroke Awareness Month, and at Pockit Diagnostics, we're proud to be a part of the effort to raise awareness and reduce the impact of this devastating condition. We're committed to making a difference in stroke. stroke.org.uk/64M Stroke Association

We're thrilled to introduce Upfront Diagnostics, the new face of rapid blood tests for stroke diagnosis! Check out our website to explore how our advanced technology is revolutionizing stroke detection. Time is life, and we're dedicated to making every second count. #TimeIsLife

Don't let time slip away. Discover Upfront Diagnostics, the game-changer in stroke diagnosis. Our new website is here! Learn how our rapid blood tests empower healthcare professionals to act swiftly, saving precious lives. Together, we can make a difference. #TimeIsLife

First training day for the RADAR study. Thanks to the Northumbria Healthcare team for hosting another important research study to improve stroke care 👏👏. Upfront Diagnostics @NIHR_NCL_MIC

We are thrilled to announce that Upfront Diagnostics has raised £1.6M to commercialise the “LVOne”, a rapid blood test for the identification of strokes. Thank you to APEX Ventures Stroke Association and SBRI Healthcare for believing in our mission. cambridgeindependent.co.uk/business/upfro…

Last week, Upfront was 1 of 4 companies invited to pitch at the House of Commons alongside 150 members of British In Vitro Diagnostics Association (BIVDA). The event was a valuable opportunity for our CEO to present the potential of our technology to MPs, members of government agencies, and key industry stakeholders.

Asaf Bank is our new Corporate Finance and Strategy. Welcome to the Upfront team! #TimeisLife

We are thrilled to announce that Upfront Diagnostics has been selected for The Innovative Devices Access Pathway (IDAP), a pioneering initiative aimed at revolutionising healthcare delivery within the NHS. gov.uk/government/new…

"We have developed a game-changing, accessible tool that could help ensure that more people suffering from stroke are in the right place at the right time to receive critical, life-restoring care,” said senior author Joshua Bernstock eurekalert.org/news-releases/…

In the TIME trial, we demonstrate game changing accuracy of a new diagnostic tool that can be administered to LVO patients immediately in the field. Congratulations Joshua Bernstock Upfront Diagnostics Brigham and Women's Neurosurgery ahajournals.org/doi/10.1161/SV…

🎉 Exciting News Alert! 🎉 📚 Our groundbreaking US research has been published in the esteemed journal "Stroke: vascular and interventional neurology" from the American Stroke Association. 🌐 Read full article here: ahajournals.org/doi/full/10.11…

Schedule a meeting 17-20 June with Upfront Diagnostics at the HLTH Europe: [email protected]